Ledger.Open graph →
SEC Form D · filed October 23, 2014

AXIM BIOTECHNOLOGIES, INC

Offering
—
Sold
—
Exemption
Rule 506(b)
Industry
Other
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Lekhram A. Changoer · New York, NYExec · DirectorDr. Philip A. Van Damme · New York, NYExec · DirectorDr. George Anastassov · New York, NYExec · DirectorDr. Philip A. Van Damme · New York, NYExec · DirectorDr. George Anastassov · New York, NYExec · DirectorLekhram A. Changoer · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗